Clinical Trial Update: Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV) [Phase 3]

View source ↗

Summary

The Phase 3 trial evaluating SPL7013 Gel to prevent recurrence of bacterial vaginosis has completed. The sponsor is Starpharma Pty Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis

Drugs mentioned

• SPL7013 Gel (SPL7013)

Snippet

Sponsor: Starpharma Pty Ltd | Conditions: Bacterial Vaginosis | Phase 3 | Status: COMPLETED